Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States.
Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
Inflammation-independent defective early B cell tolerance checkpoints in rheumatoid arthritis.
Gilenya® data confirm reducing brain shrinkage matters for people with MS due to its association with long-term disability progression
Diffusion abnormality in Balo's concentric sclerosis: clues for the pathogenesis.
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
Clinical and metabolic response to probiotic supplementation in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial.
Celastrol and Its Role in Controlling Chronic Diseases.
Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
Interactions between Neutrophils, Th17 Cells, and Chemokines during the Initiation of Experimental Model of Multiple Sclerosis.
Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
Genetics of rat neuroinflammation.
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.
Cytosolic phospholipase A2 plays a crucial role in ROS/NO signaling during microglial activation through the lipoxygenase pathway.
Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits.
Reduced Sterol Regulatory Element-Binding Protein (SREBP) Processing Through Site-1 Protease (S1P) inhibition Alters Oligodendrocyte Differentiation in vitro.
The spectrum of leukodystrophies in children: Experience at a tertiary care centre from North India.
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.
N'-(arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT₆R) antagonists with unique structural features.
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study.
Corpus callosum thickness in children: an MR pattern-recognition approach on the midsagittal image.
The Cost of Patients With Relapsing-Remitting Multiple Sclerosis Who Develop Neutralizing Antibodies While Treated With Interferon Beta.
Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple Sclerosis.
Multiple sclerosis in Brazil: A systematic review.
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.

Pages